Loading…
ABIVAX Société Anonyme is projected to rise to $152.65 by 2027, a +23% move from its current price of $124.33. ABVX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $118.63 | $124.38 | $130.41 | +0.04% |
| Aug 2 | $116.37 | $124.43 | $133.05 | +0.08% |
| Aug 3 | $114.68 | $124.48 | $135.12 | +0.12% |
| Aug 4 | $113.28 | $124.53 | $136.91 | +0.16% |
| Aug 5 | $112.07 | $124.59 | $138.50 | +0.21% |
| Aug 6 | $110.99 | $124.64 | $139.97 | +0.25% |
| Aug 7 | $110.00 | $124.69 | $141.33 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $110.00 | $124.69 | $141.33 | +0.29% |
| Week 2 | $104.74 | $125.05 | $149.29 | +0.58% |
| Week 3 | $100.94 | $125.41 | $155.80 | +0.86% |
| Week 4 | $97.89 | $125.77 | $161.58 | +1.15% |
| Week 5 | $95.31 | $126.13 | $166.91 | +1.45% |
| Week 6 | $93.06 | $126.49 | $171.93 | +1.74% |
| Week 7 | $91.06 | $126.85 | $176.71 | +2.03% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ABIVAX Société Anonyme is a clinical-stage biotechnology company that develops therapeutics harnessing the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease.
The company was incorporated in 2013 and is headquartered in Paris, France. It is categorized in Healthcare.
ABIVAX Société Anonyme (ABVX) is trading at $118.84 with a market capitalization of $10.36B, and it ranks 898. The current price anchors a forecast that begins with a neutral 2026 outlook and gradually moves higher over the long term.
The year-by-year forecast shows the average price progressing from $118.84 in 2026 to $310.81 by 2030, and continuing to $2,379.09 on average by 2050, with a max forecast reaching $5,471.90 in 2050. The implied returns (ROI) grow from 0% in 2026 to 161.5% in 2030 and up to 1901.9% by 2050, with a bullish sentiment driving the longer-horizon outlook.
A major floor 45.2% below — a decisive break under it would weaken the trend.
The nearest floor, 25.7% below — buyers have tended to step in here.
The nearest ceiling, 16.3% above — a clean break opens room to run.
A major ceiling 38.9% above — clearing it would confirm fresh momentum.
Key ABVX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ABVX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $124.22 | Buy | $124.62 | Sell |
| MA 10 | $128.42 | Sell | $127.14 | Sell |
| MA 20 | $133.99 | Sell | $127.12 | Sell |
| MA 50 | $118.31 | Buy | $122.33 | Buy |
| MA 100 | $117.77 | Buy | $118.57 | Buy |
| MA 200 | $116.69 | Buy | $107.64 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.63 | Neutral |
| Stoch RSI (14) | 28.44 | Neutral |
| CCI (20) | -110.21 | Sell |
| Williams %R (14) | -71.00 | Info |
| MACD (12,26,9) | -2.44 | Sell |
| ROC (12) | -7.84 | Sell |
| Bollinger %B (20,2) | 0.15 | Neutral |
| Stochastic %K (14) | 29.00 | Neutral |
| TRIX (15) | 0.56 | Buy |
| Awesome (5,34) | 3.14 | Buy |
| Ultimate (7,14,28) | 36.63 | Neutral |
| Momentum (10) | -13.44 | Sell |
| Aroon Osc (25) | 20.00 | Buy |
| Hull MA (9) | 120.73 | Buy |
| ADX (14) | 15.45 | Neutral |
| ATR (14) | 4.08 | Info |
The 30-day technical picture carries a bullish tilt overall, with RSI(14) at 40 and a near-term uptrend implied by the price action.
Key moving averages are $118.10 for the SMA-50 and $116.54 for the SMA-200, suggesting a constructive momentum around the current price. Support is pegged at $92.37 and resistance at $144.65, indicating a defined trading range around the recent level.
The 30-day range spans $86.62 to $163.05, and annualized volatility is 90%, underscoring higher-than-average price movement.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $72.50 | $124.33 | $190.84 | 0% | Neutral | |
| $113.60 | $152.65 | $220.98 | +23% | Bullish | |
| $138.38 | $196.09 | $301.13 | +58% | Bullish | |
| $177.59 | $263.21 | $422.83 | +112% | Bullish | |
| $223.27 | $344.56 | $574.54 | +177% | Bullish | |
| $268.41 | $430.01 | $740.43 | +246% | Bullish | |
| $261.52 | $434.12 | $769.09 | +249% | Bullish | |
| $257.73 | $442.57 | $804.36 | +256% | Bullish | |
| $289.17 | $513.08 | $954.50 | +313% | Bullish | |
| $362.17 | $663.40 | $1,260.96 | +434% | Bullish | |
| $449.74 | $958.91 | $1,991.21 | +671% | Bullish | |
| $1,279.82 | $2,844.03 | $6,541.28 | +21.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $72.50 | $124.33 | $145.72 | +0.00% |
| August 2026 | $109.33 | $130.33 | $160.46 | +4.83% |
| September 2026 | $106.69 | $129.07 | $162.53 | -0.97% |
| October 2026 | $103.67 | $126.93 | $162.67 | -1.66% |
| November 2026 | $109.73 | $135.68 | $176.37 | +6.89% |
| December 2026 | $116.18 | $144.95 | $190.84 | +6.83% |
Click any year to see its month-by-month ABVX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ABVX to range from $72.50 to $190.84 through 2026. The $124.33 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The ABVX price prediction for 2027 points to an average of $152.65 (low $113.60, high $220.98) — a potential gain of +23% on today's $124.33. Buyers look set to stay in control over this stretch.
In 2028, ABVX is projected to trade between $138.38 and $301.13, averaging $196.09 — a potential gain of +58% from today's $124.33. That is up +28% on the projected 2027 average. Momentum favours further upside here.
ABIVAX Société Anonyme's 2029 outlook centres on $263.21, within a $177.59 to $422.83 range. That is up +34% on the projected 2028 average. That marks a +112% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, ABVX could reach as high as $574.54, with a base case around $344.56 and support toward $223.27 — roughly +177% from $124.33. Momentum favours further upside here.
Expect ABVX to range from $268.41 to $740.43 through 2031. The $430.01 average target implies a +246% move from current prices. That is up +25% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The ABVX price prediction for 2032 points to an average of $434.12 (low $261.52, high $769.09) — a potential gain of +249% on today's $124.33. Momentum favours further upside here.
In 2033, ABVX is projected to trade between $257.73 and $804.36, averaging $442.57 — a potential gain of +256% from today's $124.33. That is up +2% on the projected 2032 average. Buyers look set to stay in control over this stretch.
ABIVAX Société Anonyme's 2034 outlook centres on $513.08, within a $289.17 to $954.50 range. That is up +16% on the projected 2033 average. That marks a +313% change versus current levels. Momentum favours further upside here.
By 2035, ABVX could reach as high as $1,260.96, with a base case around $663.40 and support toward $362.17 — roughly +434% from $124.33. Buyers look set to stay in control over this stretch.
Expect ABVX to range from $449.74 to $1,991.21 through 2040. The $958.91 average target implies a +671% move from current prices. That is up +45% on the projected 2035 average. Momentum favours further upside here.
The ABVX price prediction for 2050 points to an average of $2,844.03 (low $1,279.82, high $6,541.28) — a potential gain of +21.9x on today's $124.33. Buyers look set to stay in control over this stretch.
Investing $1,000 in ABVX today (≈ 8.043111 ABVX) could be worth
$22,874.88
+$21,874.88 (+2187%) by 2050 · US Dollar
Based on the average projected ABVX price of $2,844.03 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ABVXwould be worth at today's price.
$1,000 invested in ABVX on Jul 30, 2025 (≈ 14.117315 ABVX) would be worth
$1,755.21
+$755.21 (+75.5%) today · 1.76× · US Dollar
Based on a ABVX entry price of $70.83 vs. today's $124.33.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $131.16 | $947.93 | -5.2% |
| 1 month ago | $133.26 | $932.99 | -6.7% |
| 3 months ago | $117.61 | $1,057.14 | +5.7% |
| 6 months ago | $111.15 | $1,118.58 | +11.9% |
| 1 year ago | $70.83 | $1,755.21 | +75.5% |
| All time (2.8y) ago | $8.3 | $14,979.52 | +1398.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ABVX forecast.
Our base-case forecast reaches $250.00 around 2029.
Implied market cap at $250.00: $21.79B
The multi-year forecast shows a sustained bullish trajectory beyond 2026, with 2027 avg $142.61 and 2028 avg $180.35, followed by meaningful acceleration in later years. By 2030, the average forecast reaches $310.81 with a 161.5% ROI and a bullish sentiment, and by 2040 the average is $814.23 with a 585.1% ROI. By 2050, the average forecast climbs to $2,379.09 with a 1901.9% ROI and a bullish sentiment continuing.
These figures imply substantial long-term upside but should be interpreted as estimates rather than guarantees. The forecast sequence shows a progression from a neutral near-term stance in 2026 to a consistently bullish stance through 2050, with the maximums reaching as high as $5,471.90 in 2050.
Tap a question to reveal the answer.
2030 avg $310.81, min $200.47, max $520.38, ROI 161.5%, sentiment BULLISH.
Forecasts from 2027 onward show bullish sentiment with rising averages, reaching 2050 avg $2,379.09 and ROI 1901.9. Near term 2026 is neutral with avg $118.84.
Yes—the 2050 max forecast is $5,471.90; 2050 avg is $2,379.09 with ROI 1901.9 and sentiment BULLISH.
Current price $118.84; market cap $10.36B.
2026 min $72.50, avg $118.84, max $181.90; ROI 0%; sentiment NEUTRAL.
ABIVAX Société Anonyme Community Discussion
0Share your ABIVAX Société Anonyme price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.